Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis

Most prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic performance of serum direct bilirubin (DB) and developed new DB level-based prediction models for cirrhosis.Background/AimsMost prognostic p...

Full description

Saved in:
Bibliographic Details
Published in:Gut and liver Vol. 15; no. 4; pp. 599 - 605
Main Authors: Lee, Han Ah, Jung, Joon Young, Lee, Young-Sun, Jung, Young Kul, Kim, Ji Hoon, An, Hyonggin, Yim, Hyung Joon, Jeen, Yoon Tae, Yeon, Jong Eun, Byun, Kwan Soo, Um, Soon Ho, Seo, Yeon Seok
Format: Journal Article
Language:English
Published: Editorial Office of Gut and Liver 01.07.2021
Gastroenterology Council for Gut and Liver
거트앤리버 소화기연관학회협의회
Subjects:
ISSN:1976-2283, 2005-1212, 2005-1212
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Most prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic performance of serum direct bilirubin (DB) and developed new DB level-based prediction models for cirrhosis.Background/AimsMost prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic performance of serum direct bilirubin (DB) and developed new DB level-based prediction models for cirrhosis.A total of 983 hospitalized patients with liver cirrhosis were included. DB-Model for End-Stage Liver Disease (MELD) score was calculated using MELD score formula, with serum DB level replacing TB level.MethodsA total of 983 hospitalized patients with liver cirrhosis were included. DB-Model for End-Stage Liver Disease (MELD) score was calculated using MELD score formula, with serum DB level replacing TB level.Mean age of study population was 56.1 years. Alcoholic liver disease was the most frequent underlying condition (471 patients, 47.9%). Within 6 months, 144 patients (14.6%) died or received liver transplantation due to severe liver dysfunction. The area under the receiver operating characteristic curve (AUROC) for prediction of 6-month mortality with DB level was significantly higher than that with TB level (p<0.001). The AUROC of DB-MELD score for prediction of 6-month mortality was significantly higher than that of MELD score (p<0.001). Patients were randomly divided into training (n=492) and validation (n=491) cohorts. A new prognostic prediction model, "Direct Bilirubin, INR, and Creatinine" (DiBIC) score, was developed based on the most significant predictors of 6-month mortality. In training set, AUROC of DiBIC score for prediction of 6-month mortality was 0.892, which was significantly higher than that of the MELD score (0.875, p=0.017), but not different from that of DB-MELD score (0.886, p=0.272). Similar results were observed in validation set.ResultsMean age of study population was 56.1 years. Alcoholic liver disease was the most frequent underlying condition (471 patients, 47.9%). Within 6 months, 144 patients (14.6%) died or received liver transplantation due to severe liver dysfunction. The area under the receiver operating characteristic curve (AUROC) for prediction of 6-month mortality with DB level was significantly higher than that with TB level (p<0.001). The AUROC of DB-MELD score for prediction of 6-month mortality was significantly higher than that of MELD score (p<0.001). Patients were randomly divided into training (n=492) and validation (n=491) cohorts. A new prognostic prediction model, "Direct Bilirubin, INR, and Creatinine" (DiBIC) score, was developed based on the most significant predictors of 6-month mortality. In training set, AUROC of DiBIC score for prediction of 6-month mortality was 0.892, which was significantly higher than that of the MELD score (0.875, p=0.017), but not different from that of DB-MELD score (0.886, p=0.272). Similar results were observed in validation set.New prognostic models, DB-MELD and DiBIC scores, have good prognostic performance in liver cirrhosis patients, outperforming other currently available models.ConclusionsNew prognostic models, DB-MELD and DiBIC scores, have good prognostic performance in liver cirrhosis patients, outperforming other currently available models.
AbstractList Background/Aims: Most prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic performance of serum direct bilirubin (DB) and developed new DB level-based prediction models for cirrhosis. Methods: A total of 983 hospitalized patients with liver cirrhosis were included. DB-Model for End-Stage Liver Disease (MELD) score was calculated using MELD score formula, with serum DB level replacing TB level. Results: Mean age of study population was 56.1 years. Alcoholic liver disease was the most frequent underlying condition (471 patients, 47.9%). Within 6 months, 144 patients (14.6%) died or received liver transplantation due to severe liver dysfunction. The area under the receiver operating characteristic curve (AUROC) for prediction of 6-month mortality with DB level was significantly higher than that with TB level (p<0.001). The AUROC of DB-MELD score for prediction of 6-month mortality was significantly higher than that of MELD score (p<0.001). Patients were randomly divided into training (n=492) and validation (n=491) cohorts. A new prognostic prediction model, “Direct Bilirubin, INR, and Creatinine” (DiBIC) score, was developed based on the most significant predictors of 6-month mortality. In training set, AUROC of DiBIC score for prediction of 6-month mortality was 0.892, which was significantly higher than that of the MELD score (0.875, p=0.017), but not different from that of DB-MELD score (0.886, p=0.272). Similar results were observed in validation set. Conclusions: New prognostic models, DB-MELD and DiBIC scores, have good prognostic performance in liver cirrhosis patients, outperforming other currently available models.
Background/Aims: Most prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic performance of serum direct bilirubin (DB) and developed new DB level-based prediction models for cirrhosis. Methods: A total of 983 hospitalized patients with liver cirrhosis were included. DB-Model for End-Stage Liver Disease (MELD) score was calculated using MELD score formula, with serum DB level replacing TB level. Results: Mean age of study population was 56.1 years. Alcoholic liver disease was the most frequent underlying condition (471 patients, 47.9%). Within 6 months, 144 patients (14.6%) died or received liver transplantation due to severe liver dysfunction. The area under the receiver operating characteristic curve (AUROC) for prediction of 6-month mortality with DB level was significantly higher than that with TB level (p<0.001). The AUROC of DB-MELD score for prediction of 6-month mortality was significantly higher than that of MELD score (p<0.001). Patients were randomly divided into training (n=492) and validation (n=491) cohorts. A new prognostic prediction model, “Direct Bilirubin, INR, and Creatinine” (DiBIC) score, was developed based on the most significant predictors of 6-month mortality. In training set, AUROC of DiBIC score for prediction of 6-month mortality was 0.892, which was significantly higher than that of the MELD score (0.875, p=0.017), but not different from that of DB-MELD score (0.886, p=0.272). Similar results were observed in validation set. Conclusions: New prognostic models, DB-MELD and DiBIC scores, have good prognostic performance in liver cirrhosis patients, outperforming other currently available models. KCI Citation Count: 0
Most prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic performance of serum direct bilirubin (DB) and developed new DB level-based prediction models for cirrhosis.Background/AimsMost prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic performance of serum direct bilirubin (DB) and developed new DB level-based prediction models for cirrhosis.A total of 983 hospitalized patients with liver cirrhosis were included. DB-Model for End-Stage Liver Disease (MELD) score was calculated using MELD score formula, with serum DB level replacing TB level.MethodsA total of 983 hospitalized patients with liver cirrhosis were included. DB-Model for End-Stage Liver Disease (MELD) score was calculated using MELD score formula, with serum DB level replacing TB level.Mean age of study population was 56.1 years. Alcoholic liver disease was the most frequent underlying condition (471 patients, 47.9%). Within 6 months, 144 patients (14.6%) died or received liver transplantation due to severe liver dysfunction. The area under the receiver operating characteristic curve (AUROC) for prediction of 6-month mortality with DB level was significantly higher than that with TB level (p<0.001). The AUROC of DB-MELD score for prediction of 6-month mortality was significantly higher than that of MELD score (p<0.001). Patients were randomly divided into training (n=492) and validation (n=491) cohorts. A new prognostic prediction model, "Direct Bilirubin, INR, and Creatinine" (DiBIC) score, was developed based on the most significant predictors of 6-month mortality. In training set, AUROC of DiBIC score for prediction of 6-month mortality was 0.892, which was significantly higher than that of the MELD score (0.875, p=0.017), but not different from that of DB-MELD score (0.886, p=0.272). Similar results were observed in validation set.ResultsMean age of study population was 56.1 years. Alcoholic liver disease was the most frequent underlying condition (471 patients, 47.9%). Within 6 months, 144 patients (14.6%) died or received liver transplantation due to severe liver dysfunction. The area under the receiver operating characteristic curve (AUROC) for prediction of 6-month mortality with DB level was significantly higher than that with TB level (p<0.001). The AUROC of DB-MELD score for prediction of 6-month mortality was significantly higher than that of MELD score (p<0.001). Patients were randomly divided into training (n=492) and validation (n=491) cohorts. A new prognostic prediction model, "Direct Bilirubin, INR, and Creatinine" (DiBIC) score, was developed based on the most significant predictors of 6-month mortality. In training set, AUROC of DiBIC score for prediction of 6-month mortality was 0.892, which was significantly higher than that of the MELD score (0.875, p=0.017), but not different from that of DB-MELD score (0.886, p=0.272). Similar results were observed in validation set.New prognostic models, DB-MELD and DiBIC scores, have good prognostic performance in liver cirrhosis patients, outperforming other currently available models.ConclusionsNew prognostic models, DB-MELD and DiBIC scores, have good prognostic performance in liver cirrhosis patients, outperforming other currently available models.
Author Yim, Hyung Joon
Byun, Kwan Soo
Jung, Young Kul
Kim, Ji Hoon
Seo, Yeon Seok
Jung, Joon Young
An, Hyonggin
Yeon, Jong Eun
Um, Soon Ho
Lee, Han Ah
Lee, Young-Sun
Jeen, Yoon Tae
AuthorAffiliation 1 Departments of Internal Medicine, Korea University College of Medicine, Seoul, Korea
2 Departments of Biostatistics, Korea University College of Medicine, Seoul, Korea
AuthorAffiliation_xml – name: 1 Departments of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– name: 2 Departments of Biostatistics, Korea University College of Medicine, Seoul, Korea
Author_xml – sequence: 1
  givenname: Han Ah
  orcidid: 0000-0003-4082-1121
  surname: Lee
  fullname: Lee, Han Ah
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 2
  givenname: Joon Young
  orcidid: 0000-0003-4579-8709
  surname: Jung
  fullname: Jung, Joon Young
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 3
  givenname: Young-Sun
  orcidid: 0000-0001-6396-0859
  surname: Lee
  fullname: Lee, Young-Sun
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 4
  givenname: Young Kul
  orcidid: 0000-0002-6566-1382
  surname: Jung
  fullname: Jung, Young Kul
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Ji Hoon
  orcidid: 0000-0003-3924-0434
  surname: Kim
  fullname: Kim, Ji Hoon
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Hyonggin
  orcidid: 0000-0002-0566-758X
  surname: An
  fullname: An, Hyonggin
  organization: Department of Biostatistics, Korea University College of Medicine, Seoul, Korea
– sequence: 7
  givenname: Hyung Joon
  orcidid: 0000-0002-6036-2754
  surname: Yim
  fullname: Yim, Hyung Joon
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 8
  givenname: Yoon Tae
  orcidid: 0000-0003-0220-3816
  surname: Jeen
  fullname: Jeen, Yoon Tae
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 9
  givenname: Jong Eun
  orcidid: 0000-0002-0510-7371
  surname: Yeon
  fullname: Yeon, Jong Eun
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 10
  givenname: Kwan Soo
  orcidid: 0000-0003-4031-842X
  surname: Byun
  fullname: Byun, Kwan Soo
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 11
  givenname: Soon Ho
  orcidid: 0000-0002-6390-2218
  surname: Um
  fullname: Um, Soon Ho
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
– sequence: 12
  givenname: Yeon Seok
  orcidid: 0000-0003-4171-6331
  surname: Seo
  fullname: Seo, Yeon Seok
  organization: Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738968$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNplkk1vEzEQhi1URNOCxE_wEQ4pttf74QtSCV-RgqhQ4GrNemcTt46d2k4R_x4naYGK01iex49ej-aMnPjgkZCXnF3UjKk3K-8E4y1_QiaCsXrKBRcnZMJV20yF6KpTcpbSNWMNF239jJxWlVCV7PiEbN_biCbTd9bZuOutp_NEv4SI9Ae4HfQOaV6Dp8uQwf1DjSHSq4iDNdn6VTmGlQ_JJlp6V5At-pzoT5vXdGHvMNKZjXG9B56TpyO4hC_u6zn5_vHDcvZ5uvj6aT67XEyNlCpPTYMl96Ck6A3vG17i9tCbWnBTSeQNyq4VwFUtFHQtCFGNILBWpUiBLVTn5PXR6-Oob4zVAeyhroK-ifry23KuVSdr1orCzo_sEOBab6PdQPx1eHC4CHGlIWZrHOq6qoaxr9WoeiUBmm7EHnAQTPJqGIa96-3Rtd31GxxMGUQE90j6uOPtumS60135r-jaInh1L4jhdocp641NBp0Dj2GXtJBN19StlLKgF0fUxJBSxFEbm8vww95sneZM79dDP6zHX_efBw-5_kN_A_wlvHw
CitedBy_id crossref_primary_10_1016_j_ecoenv_2025_118767
crossref_primary_10_1038_s41598_025_02960_6
crossref_primary_10_1038_s41598_025_91298_0
crossref_primary_10_1097_MD_0000000000028752
crossref_primary_10_2147_CEG_S438140
crossref_primary_10_3389_fcdhc_2025_1617641
crossref_primary_10_1080_07853890_2023_2184859
crossref_primary_10_1016_j_clinre_2024_102507
crossref_primary_10_1097_MEG_0000000000002535
crossref_primary_10_3389_fonc_2024_1406512
crossref_primary_10_1109_JPHOT_2024_3376474
crossref_primary_10_1007_s00011_025_02049_w
crossref_primary_10_1097_MD_0000000000043051
crossref_primary_10_1007_s00464_022_09698_6
crossref_primary_10_1016_j_eclinm_2024_103001
crossref_primary_10_1186_s12876_021_01892_5
crossref_primary_10_1097_CM9_0000000000002248
crossref_primary_10_1515_med_2022_0549
crossref_primary_10_3389_fmed_2023_1286510
crossref_primary_10_1007_s11356_022_25072_4
crossref_primary_10_1177_00220345231196536
crossref_primary_10_1007_s10620_022_07687_2
crossref_primary_10_3350_cmh_2024_0349
crossref_primary_10_1007_s42044_023_00138_9
Cites_doi 10.1016/S1665-2681(19)30910-X
10.1097/MCG.0000000000000208
10.1046/j.1365-2036.2003.01647.x
10.3350/cmh.2017.0077
10.1016/j.jhep.2005.10.013
10.1016/j.transproceed.2018.08.021
10.1002/hep.24121
10.1111/j.1572-0241.2007.01370.x
10.1056/NEJM199810223391707
10.3350/cmh.2018.1005
10.3350/cmh.2013.19.2.105
10.1016/j.jhep.2004.02.010
10.2174/138161209789058237
10.3350/cmh.2018.0034
10.1111/jgh.14387
10.1148/radiology.148.3.6878708
10.1053/jhep.2001.22172
10.1016/j.jhep.2018.12.030
10.1016/j.jhep.2015.03.031
10.1097/MD.0000000000002877
10.1053/j.gastro.2008.08.004
10.1007/BF02232966
10.1056/NEJMoa0801209
10.1002/hep.1840100102
10.1001/jama.1965.03080060049009
10.1053/j.gastro.2011.02.017
ContentType Journal Article
Copyright Copyright © Gut and Liver. 2021
Copyright_xml – notice: Copyright © Gut and Liver. 2021
DBID AAYXX
CITATION
7X8
5PM
DOA
ACYCR
DOI 10.5009/gnl20171
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2005-1212
EndPage 605
ExternalDocumentID oai_kci_go_kr_ARTI_9845072
oai_doaj_org_article_533dfb59f9b94aa68febaed20413ddd2
PMC8283287
10_5009_gnl20171
GroupedDBID ---
5-W
8JR
AAKDD
AAYXX
ABDBF
ACUHS
ACYCR
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
E3Z
EBD
EF.
F5P
GROUPED_DOAJ
GX1
HYE
HZB
OK1
RPM
7X8
5PM
53G
9ZL
ID FETCH-LOGICAL-c449t-c6e283d942bc1b61934babc521c34e16e4872a19529a87a223fa2e593fa42e7a3
IEDL.DBID DOA
ISICitedReferencesCount 29
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000679672900014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1976-2283
2005-1212
IngestDate Sun Mar 09 07:51:49 EDT 2025
Mon Nov 10 04:20:16 EST 2025
Tue Nov 04 01:51:53 EST 2025
Sun Nov 09 12:08:48 EST 2025
Sat Nov 29 01:46:43 EST 2025
Tue Nov 18 21:19:32 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c449t-c6e283d942bc1b61934babc521c34e16e4872a19529a87a223fa2e593fa42e7a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Han Ah Lee and Joon Young Jung contributed equally to this work as first authors.
ORCID 0000-0003-4082-1121
0000-0002-0510-7371
0000-0003-4031-842X
0000-0002-6390-2218
0000-0001-6396-0859
0000-0002-6036-2754
0000-0003-4579-8709
0000-0003-0220-3816
0000-0003-4171-6331
0000-0003-3924-0434
0000-0002-0566-758X
0000-0002-6566-1382
OpenAccessLink https://doaj.org/article/533dfb59f9b94aa68febaed20413ddd2
PMID 33293481
PQID 2468657444
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_9845072
doaj_primary_oai_doaj_org_article_533dfb59f9b94aa68febaed20413ddd2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8283287
proquest_miscellaneous_2468657444
crossref_citationtrail_10_5009_gnl20171
crossref_primary_10_5009_gnl20171
PublicationCentury 2000
PublicationDate 2021-07-01
PublicationDateYYYYMMDD 2021-07-01
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-01
  day: 01
PublicationDecade 2020
PublicationTitle Gut and liver
PublicationYear 2021
Publisher Editorial Office of Gut and Liver
Gastroenterology Council for Gut and Liver
거트앤리버 소화기연관학회협의회
Publisher_xml – name: Editorial Office of Gut and Liver
– name: Gastroenterology Council for Gut and Liver
– name: 거트앤리버 소화기연관학회협의회
References ref13
ref12
ref15
ref14
ref11
ref10
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref18
  doi: 10.1016/S1665-2681(19)30910-X
– ident: ref1
  doi: 10.1097/MCG.0000000000000208
– ident: ref27
  doi: 10.1046/j.1365-2036.2003.01647.x
– ident: ref5
  doi: 10.3350/cmh.2017.0077
– ident: ref7
  doi: 10.1016/j.jhep.2005.10.013
– ident: ref3
  doi: 10.1016/j.transproceed.2018.08.021
– ident: ref16
  doi: 10.1002/hep.24121
– ident: ref28
  doi: 10.1111/j.1572-0241.2007.01370.x
– ident: ref14
  doi: 10.1056/NEJM199810223391707
– ident: ref4
  doi: 10.3350/cmh.2018.1005
– ident: ref2
  doi: 10.3350/cmh.2013.19.2.105
– ident: ref25
  doi: 10.1016/j.jhep.2004.02.010
– ident: ref15
  doi: 10.2174/138161209789058237
– ident: ref6
  doi: 10.3350/cmh.2018.0034
– ident: ref22
  doi: 10.1111/jgh.14387
– ident: ref17
  doi: 10.1148/radiology.148.3.6878708
– ident: ref11
– ident: ref9
  doi: 10.1053/jhep.2001.22172
– ident: ref23
  doi: 10.1016/j.jhep.2018.12.030
– ident: ref13
  doi: 10.1016/j.jhep.2015.03.031
– ident: ref24
  doi: 10.1097/MD.0000000000002877
– ident: ref21
  doi: 10.1053/j.gastro.2008.08.004
– ident: ref12
  doi: 10.1007/BF02232966
– ident: ref20
  doi: 10.1056/NEJMoa0801209
– ident: ref8
– ident: ref26
  doi: 10.1002/hep.1840100102
– ident: ref10
  doi: 10.1001/jama.1965.03080060049009
– ident: ref19
  doi: 10.1053/j.gastro.2011.02.017
SSID ssj0061275
Score 2.4026177
Snippet Most prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study investigated prognostic...
Background/Aims: Most prognostic prediction models for patients with liver cirrhosis include serum total bilirubin (TB) level as a component. This study...
SourceID nrf
doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 599
SubjectTerms direct bilirubin
liver cirrhosis
Original
prediction model
prognosis
내과학
Title Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis
URI https://www.proquest.com/docview/2468657444
https://pubmed.ncbi.nlm.nih.gov/PMC8283287
https://doaj.org/article/533dfb59f9b94aa68febaed20413ddd2
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738968
Volume 15
WOSCitedRecordID wos000679672900014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Gut and Liver, 2021, 15(4), , pp.599-605
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2005-1212
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0061275
  issn: 1976-2283
  databaseCode: DOA
  dateStart: 20070101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZtKKWX0ifdPoJSCj2Z7MqyJR2b0NBAEvaQlr0JPROTxQ7ybn9_Z2RvWEOhl55krLGRR4_5Rhp_Q8gXAzbT-xgKaX1Z8BhYYWzJC0xeJISR0fjMrn8hrq7kaqWWe6m-MCZsoAceFHcMcMRHW6morOLG1DIGa4Jnc1h9vfd59QXUs3OmhjW4RtryfJ4s6gIJXgba2QoAxfFNu2ZIEjMxRJmvH8xLm-IEak4DJfcsz9kL8nyEjPTb0NSX5FFoX5Gnl-Oh-GtyPyxb9KRZN2kLni497-lllwL9hUzedh0o7o_T6w6A9p4UwFW6TPgaDH2Gyw6D7pqeQt1yoFvtKe7T0gsM3qCnTUq3KPCG_Dz7fn36oxgTKRSOc7UpXB1AB15xZt3CgstUcmusA8vtSh4WdQCvhZmFqpgyUhhADNGwUCkoOAvClG_JQdu14R2h3qhKCud8LQwH31CxuXP4c-3chTIyOyNfd1rVbmQZx2QXaw3eBupf7_Q_I0cPkvcDs8ZfZE6wYx7qkQs734ARoscRov81QmbkM3SrvnNNfh7Lm07fJQ0ew7lWkgMkBqGjXa9rmGB4amLa0G17zXgt60pwzmdETIbDpFnTmra5zVTdEjNBSfH-f3zHB_KMYUBNjhX-SA42aRs-kSfu96bp0yF5LFbyMM-CP0V3EE0
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Direct+Bilirubin+Is+More+Valuable+than+Total+Bilirubin+for+Predicting+Prognosis+in+Patients+with+Liver+Cirrhosis&rft.jtitle=Gut+and+liver&rft.au=Lee%2C+Han+Ah&rft.au=Jung%2C+Joon+Young&rft.au=Lee%2C+Young-Sun&rft.au=Jung%2C+Young+Kul&rft.date=2021-07-01&rft.issn=1976-2283&rft.eissn=2005-1212&rft.volume=15&rft.issue=4&rft.spage=599&rft.epage=605&rft_id=info:doi/10.5009%2Fgnl20171&rft.externalDBID=n%2Fa&rft.externalDocID=10_5009_gnl20171
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1976-2283&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1976-2283&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1976-2283&client=summon